✦ LIBER ✦

Ifosfamide, Idarubicin, and Etoposide in Relapsed/Refractory Hodgkin Disease or Non-Hodgkin Lymphoma: A Salvage Regimen with High Response Rates before Autologous Stem Cell Transplantation

✍ Scribed by Basak Oyan; Yener Koc; Evren Ozdemir; Ayse Kars; Alev Turker; Gulten Tekuzman; Emin Kansu

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of relapsed or refractory Hodg

✍ Dr. Aaron P. Rapoport; Jacob M. Rowe; Joanna M. Heal; Martin A. Tanner; John F. 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 644 KB

Prognostic Significance of FDG-PET in Re

✍ Jacob P. Smeltzer; Amanda F. Cashen; Qin Zhang; Andrew Homb; Farrokh Dehdashti; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 257 KB

Mitoxantrone, carboplatin, cytosine arab

✍ Federica Sorá; Nicola Piccirillo; Patrizia Chiusolo; Luca Laurenti; Roberto Marr 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB

A Phase I Trial of High-Dose Clofarabine

✍ Shivani Srivastava; David Jones; Lisa L. Wood; Jennifer E. Schwartz; Robert P. N 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 324 KB

Phase II study of a salvage regimen usin

✍ Yasuhiro Oki; Michinori Ogura; Harumi Kato; Ako Kikuchi; Hirofumi Taji; Yoshitoy 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

Double High Dose Salvage Therapy With Do

✍ M. Shafey; Q. Duan; J.A. Russell; P. Duggan; A. Balogh; D.A. Stewart 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 98 KB